CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 60 enrolled
Drug / intervention
Soft tissue augmentation at the buccal aspect of single implantsprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04210596
NCT04210596N/AActive

A Multicenter Randomized Controlled Study Comparing Connective Tissue Graft with Collagen Matrix to Re-establish Convexity At the Buccal Aspect of Single Dental Implants

University Ghent·interventional·Posted Dec 24, 2019·Updated Mar 6, 2025

In Brief

A clinical study evaluating Soft tissue augmentation at the buccal aspect of single implants for Buccal Soft Tissue Profile (BSP). Active but no longer recruiting, targeting 60 participants across 1 site.

Detailed Summary

Patients in need of a single implant in the premaxilla and presenting with a horizontal buccal soft tissue defect at the single tooth gap will be invited to participate in a multicenter RCT. Prior to surgery, a small-field low-dose CBCT is taken since a buccopalatal bone dimension of at least 6 mm at the central and crestal aspect of the single tooth gap is required to ensure complete embedding of an implant by bone. Sixty patients will be randomly allocated to the test group or control group in 6 centers. Each center receives 10 sealed envelopes (5 are internally labelled with 'test group' and 5 with 'control group'). For each patient a digital planning is performed in implant planning software and a tooth-supported surgical guide is fabricated. In the control group, a single implant is placed following flap elevation and surgical guide installation. Then, a CTG from the palate is positioned under the buccal mucosa to thicken the tissues. A provisional restoration is placed at the day of surgery, which is replaced by a permanent one 3m later. Patients in the test group are treated in the same way, yet a CM (Fibro-Gide®) is used instead of a CTG. Changes in the buccal soft tissue profile are registered over time by superimposing intra-oral scans in SMOP® software. Secondary outcomes included clinical, aesthetic and patient-reported outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium

Timeline

N/AActiveOverdue
2020202120222023202420252026
First PostedDec 24, 2019
Enrollment StartSep 1, 2019
Primary CompletionDec 31, 2025
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 6.5 years ago

Interventions

Soft tissue augmentation at the buccal aspect of single implantsprocedure

Soft tissue augmentation is performed following mucoperiosteal flap elevation at the buccal aspect of single implants. The connective tissue graft (control) or collagen matrix (test) is inserted in the buccal pouch and attached with monofilament sutures.